What are Privia Health Group, Inc.'s total assets?

Privia Health Group, Inc. (PRVA) holds $1.4B in total assets, up 19.8% year over year.

How much debt does Privia Health Group, Inc. have?

Privia Health Group, Inc. carries $9.0M in total debt against $753.1M of shareholders' equity, a debt-to-equity ratio of 0.01.

How much cash does Privia Health Group, Inc. have?

Privia Health Group, Inc. holds $419.5M in cash and equivalents.

Can Privia Health Group, Inc. cover its short-term obligations?

Its current ratio is 1.61 — current assets exceed current liabilities.

Where does Privia Health Group, Inc.'s balance sheet data come from?

Every line is extracted from Privia Health Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Privia Health Group, Inc. PRVA Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$479.69M-2.3%	$491.15M+26.1%	$389.51M+11.9%	$347.99M+8.6%
Accounts receivable, net	$1.73B+20.2%	$1.44B+18.0%	$1.22B+49.7%	$816.08M+77.6%
Prepaid expenses and other current assets	$138.2M+33.6%	$103.47M+46.6%	$70.58M+25.2%	$56.35M+68.5%
Total current assets	$911M+9.1%	$834.82M+19.1%	$700.8M+27.0%	$551.96M+23.6%
Property and equipment, net	$504K-59.4%	$1.24M-46.6%	$2.33M-31.3%	$3.39M-24.8%
Accumulated depreciation	$29.28M+45.6%	$20.11M+44.2%	$13.94M+208%	$4.53M+37.3%
Operating lease right-of-use assets	$8.79M+82.1%	$4.83M-27.0%	$6.61M-18.3%	$8.09M-16.0%
Goodwill	$209.84M+48.2%	$141.62M+2.1%	$138.75M+9.3%	$126.94M-0.8%
Intangible assets, net	$215.92M+96.6%	$109.81M+2.0%	$107.63M+87.6%	$57.39M-3.9%
Deferred tax assets	$65.43M-45.3%	$119.59M-18.1%	$146M+25.8%	$116.06M+36.8%
Other non-current assets	$21.04M+23.2%	$17.09M+99.1%	$8.58M+83.2%	$4.68M+3.6%
Total noncurrent assets	$458.38M+52.3%	$300.96M+0.6%	$299.1M+24.2%	$240.85M+0.5%
Total assets	$1.37B+20.6%	$1.14B+13.6%	$999.9M+26.1%	$792.81M+15.5%
Accounts payable	$35.16M+9.2%	$32.18M+17.8%	$27.33M+1.5%	$26.92M+84.9%
Accrued expenses	$55.28M+20.7%	$45.81M+58.5%	$28.9M+16.9%	$24.73M+6.4%
Operating lease liabilities, current	$2.2M-13.8%	$2.55M-16.1%	$3.04M+1.0%	$3.01M+4.1%
Total current liabilities	$568.52M+26.6%	$449.15M+16.1%	$386.95M+46.4%	$264.27M+38.8%
Operating lease liabilities, non-current	$7.33M+141%	$3.04M-42.1%	$5.25M-38.2%	$8.49M-23.1%
Other non-current liabilities	$2.58M+1,589%	$153K-51.1%	$313K-68.7%	$1M-66.7%
Total noncurrent liabilities	$9.92M+211%	$3.19M-42.6%	$5.56M-41.4%	$9.49M-79.2%
Total liabilities	$578.44M+27.9%	$452.34M+15.2%	$392.51M+43.4%	$273.76M+15.9%
Common stock	1B+83,026%	1.2M+1.8%	1.2M+3.0%	1.1M+6.5%
Additional paid-in capital	$892.29M+9.7%	$813.21M+7.9%	$753.87M+5.5%	$714.64M+12.7%
Retained earnings	-$156.31M+12.8%	-$179.23M+7.4%	-$193.61M+10.7%	-$216.69M-4.1%
Noncontrolling interests	$53.73M+11.3%	$48.26M+5.0%	$45.95M+130%	$19.96M-14.4%
Total stockholders' equity	$737.22M+16.1%	$635.18M+13.1%	$561.44M+12.5%	$499.09M+16.9%
Total liabilities and stockholders' equity	$1.37B+20.6%	$1.14B+13.6%	$999.9M+26.1%	$792.81M+15.5%
Deferred Tax Assets and Other Non-Current Assets	$21.04M+23.2%	$17.09M+99.1%	$8.58M+83.2%	$4.68M+3.6%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	——	——
Finite Lived Intangible Assets - Gross	$245.2M+88.7%	$129.92M+6.9%	$121.57M+84.3%	$65.97M+1.5%
Net Investment in Lease	$8.79M+82.1%	$4.83M-27.0%	$6.61M-18.3%	$8.09M-16.0%
Deferred tax assets	$2.27M-91.4%	$26.38M-25.0%	$35.2M-12.8%	$40.37M+21.0%
Intangible assets — net	$215.92M+96.6%	$109.81M+2.0%	$107.63M+87.6%	$57.39M-3.9%
Operating lease right-of-use assets	$8.79M+82.1%	$4.83M-27.0%	$6.61M-18.3%	$8.09M-16.0%
Other non-current assets	$21.04M+23.2%	$17.09M+99.1%	$8.58M+83.2%	$4.68M+3.6%
Operating Lease Right-of-Use Assets in Other Assets	$8.79M+82.1%	$4.83M-27.0%	$6.61M-18.3%	$8.09M-16.0%
Software and Technology Licenses, Net	$21.04M+23.2%	$17.09M+99.1%	$8.58M+83.2%	$4.68M+3.6%
Accounts payable and other current liabilities (Note 11)	$96.8M+18.1%	$81.99M+41.8%	$57.83M+9.5%	$52.84M+14.9%
Total debt	$9.53M+70.5%	$5.59M-32.6%	$8.29M-27.9%	$11.5M-74.9%
Common Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common Stock Shares Issued	123.6M+2.7%	120.3M+1.8%	118.2M+3.1%	114.7M+6.4%
Common Stock Shares Outstanding	$102.1M+9.7%	$93.07M-32.6%	$138.03M-30.2%	$197.7M-50.3%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$1.24M+2.7%	$1.2M+1.8%	$1.18M+3.0%	$1.15M+6.5%
Number of Exercisable Options	——	——	——	——
Share-Based Payment Award Options Outstanding - Number	7.5M-11.6%	8.5M-13.2%	9.8M-25.5%	13.2M-33.8%
Share-Based Payment - Unrecognized Cost of Nonvested Awards	——	——	——	——
Weighted Average Exercise Price of Outstanding Options	$10.26+2.3%	$10.03+10.7%	$9.06+15.3%	$7.86+33.2%
Accrued employee compensation and benefits	$33.55M+459%	$6M+0.4%	$5.97M-3.3%	$6.18M-17.5%
Common stock, par value (in dollars per share)	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common stock, shares authorized (in shares)	$1B0.0%	$1B0.0%	$1B0.0%	$1B0.0%
Common stock, shares issued (in shares)	$123.6M+2.7%	$120.31M+1.8%	$118.22M+3.1%	$114.69M+6.4%
Common Stock, Shares, Outstanding	$123.6M+2.7%	$120.31M+1.8%	$118.22M+3.1%	$114.69M+6.4%
Deferred income taxes	$0—	——	——	——
Unrecognized compensation cost related to non-vested awards	——	——	——	——
Thereafter	——	——	——	——
Finite-Lived Intangible Assets, Accumulated Amortization	$29.28M+45.6%	$20.11M+44.2%	$13.94M+62.4%	$8.58M+64.0%
2028	——	——	——	——
2030	——	——	——	——
Remainder of 2026	——	——	——	——
2027	——	——	——	——
2029	——	——	——	——
Gross Carrying Amount	$245.2M+88.7%	$129.92M+6.9%	$121.57M+84.3%	$65.97M+1.5%
Liability for Unpaid Claims and Claims Adjustment Expense, Net	$469.52M+28.8%	$364.61M+11.8%	$326.08M+56.4%	$208.42M+48.1%
Noncontrolling interests in subsidiaries	$53.73M+11.3%	$48.26M+5.0%	$45.95M+130%	$19.96M-14.4%
Other accrued liabilities	$55.28M+20.7%	$45.81M+58.5%	$28.9M+16.9%	$24.73M+6.4%
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$7.53M-11.6%	$8.53M-13.2%	$9.82M-25.5%	$13.18M-33.8%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$10.26+2.3%	$10.03+10.7%	$9.06+15.3%	$7.86+33.2%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$102.1M+9.7%	$93.07M-32.6%	$138.03M-30.2%	$197.7M-50.3%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	——	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——
Remainder of Fiscal Year 2025	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Privia Health Group, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Privia Health Group, Inc.'s total assets?: Privia Health Group, Inc. (PRVA) holds $1.4B in total assets, up 19.8% year over year.
How much debt does Privia Health Group, Inc. have?: Privia Health Group, Inc. carries $9.0M in total debt against $753.1M of shareholders' equity, a debt-to-equity ratio of 0.01.
How much cash does Privia Health Group, Inc. have?: Privia Health Group, Inc. holds $419.5M in cash and equivalents.
Can Privia Health Group, Inc. cover its short-term obligations?: Its current ratio is 1.61 — current assets exceed current liabilities.
Where does Privia Health Group, Inc.'s balance sheet data come from?: Every line is extracted from Privia Health Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.